Identification of neuronal nitric oxide synthase (nNOS) in human penis: A potential role of reduced neuronally-derived nitric oxide in erectile dysfunction

Current Pharmaceutical Biotechnology

Volumn 12, Issue 9, 2011, Pages 1316-1321

  Dashwood, Michael R ^a   Crump, Ann ^a   Shi Wen, Xu ^a   Loesch, Andrzej ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Corpus cavernosum; Erectile dysfunction; Nerve; Neuronal nitric oxide synthase

Indexed keywords

NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ARTICLE; CONTROLLED STUDY; DENSITY; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME LOCALIZATION; ERECTILE DYSFUNCTION; HUMAN; HUMAN TISSUE; MALE; NERVE DEGENERATION; PENIS; PROTEIN EXPRESSION; TISSUE DISTRIBUTION;

EID: 80052230988     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920111798280965     Document Type: Article

References (41)

1. Kaiser, F.E. Sexuality in the elderly. Urol. Clin. North. Am., 1996, 23(1), 99-109.
2. Lincoln, J.; Crowe, R.; Blacklay, P.F.; Pryor, J.P.; Lumley, J.S.P.; Burnstock, G. Changes in VIPergic, cholinergic and adrenergic innervation of human penile tissue in diabetic and non-diabetic impotent males. J. Urol., 1987, 137(5), 1053-1059.
3. Saenz de Tejada, I.; Goldstain, I.; Azadzoi, K.; Krane, R.J.; Cohen, R.A. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N. Engl. J. Med., 1989, 320(16), 1025-1030.
4. Azadzoi, K.M.; Saenz de Tejada, I. Diabetes mellitus impairs neurogenic and endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle. J. Urol., 1992, 148(5), 1587-1591.
5. Thomas, G.N.; Tomlinson, B.; Abdullah, A.S.; Yeung, V.T.; Chan, J.C.; Wong, K.S. Association of erectile dysfunction with cardiovascular risk factors and increasing existing vascular disease in male chinese type 2 diabetic patients. Diabetes Care, 2005, 28(8), 2051-2053.
6. Cameron, N.E.; Cotter, M.A. Erectile dysfunction and diabetes mellitus: mechanistic considerations from studies in experimental models. Curr. Diabetes Rev., 2007, 3(3), 149-158.
7. Sullivan, M.E.; Bell, C.R.W.; Dashwood, M.R.; Miller, M.A.W.; Thompson, C.S.; Mikhailidis, D.P.; Morgan, R.J. Autoradiographic localisation of nitric oxide synthase binding sites in normal and diabetic rat corpus cavernosum. Eur. Urol., 1996, 30(4), 506-511.
8. Keegan, A.; Cotter, M.A.; Cameron, N.E. Effects of diabetes and treatment with the antioxidant alpha-lipoic acid on endothelial and neurogenic responses of corpus cavernosum in rats. Diabetologia, 1999, 42(3), 343-350.
9. Sullivan, M.E.; Mumtaz, F.H.; Dashwood, M.R.; Thompson, C.S.; Naseem, K.M.; Bruckdorfer, K.R.; Mikhailidis, D.P.; Morgan, R.J. Enhanced relaxation of diabetic rabbit cavernosal smooth muscle in response to nitric oxide: potential relevance to erectile dysfunction. Int. J. Impot. Res., 2002, 14(2), 523-532.
10. Nangle, M.R.; Cotter, M.A.; Cameron, N.E. An in vitro investigation of aorta and corpus cavernosum from eNOS and nNOS genedeficient mice. Pflugers Arch., 2004, 448(2), 139-145.
11. Pickard, R.S.; Powell, P.H.; Zar, M.A. Nitric oxide and cyclic GMP formation following relaxant nerve stimulation in isolated human corpus cavernosum Br. J. Urol., 1995, 75(4), 516-522.
12. Choi, Y.D.; Mah, S.Y.; Xin, Z.C.; Choi, H.K. The distribution of nitric oxide synthase inhuman corpus cavernosum on various impotent pateients. Yonsei Med. J., 1997, 38(3), 125-132.
13. Ayajiki, K.; Toda, N.; Okamura, T. Nitroxidergic (nitrergic) nerve and erectile dysfunction. Nippon Yakurigaku Zasshi., 2002, 119(1), 21-28.
14. Toda, N.; Ayajiki, K.; Okamura, T. Nitric oxide and penile erectile function. Pharmacol. Ther., 2005, 106(2), 233-266.
15. Ghasemi, M.; Sadeghipour, H.; Mani, A.R.; Tavakoli, S.; Hajrasouliha, A.R.; Ebrahimi, F.; Dehpour, A.R. Effect of anandamide on nonadrenergic noncholinergic-mediated relaxation of rat corpus cavernosum. Eur. J. Pharmacol., 2006, 544(1/3), 138-114.
16. Ayajiki, K.; Hayashida, H.; Tawa, M.; Okamura, T.; Toda, N. Characterization of nitrergic function in monkey penile erection in vivo and in vitro. Hypertens. Res., 2009, 32(8), 685-689.
17. Palmer, R.M.; Ferrige, A.G.; Moncada, S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 1987, 327(6122), 524-526.
18. Palmer, R.M.J.; Ashton, D.S.; Moncada, S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature, 1988, 333(6174), 664-666.
19. Bredt, D.S.; Snyder, S.H. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA, 1990, 87(2), 682-685.
20. Forstermann, U.; Schmidt, H.H.W.; Pollock, J.S.; Sheng, H.; Mitchell, J.; Warner, T.D.; Nakane, M.; Murad, F. Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem. Pharmacol., 1991, 42(10), 1849-1857.
21. Moncada, S.; Palmer, R.M.; Higgs, E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 1991, 43(2), 109-142.
22. Sadeghipour, H.; Ghasemi, M.; Ebrahimi, F.; Dehpour, A.R. Effect of lithium on endothelium-dependent and neurogenic relaxation of rat corpus cavernosum: role of nitric oxide pathway. Nitric Oxide., 2007, 16(1), 54-63.
23. El-Sakka, A.I.; Lin, C.S.; Chui, R.M.; Dahiya, R.; Lue, T.F. Effects of diabetes on nitric oxide synthase and growth factor genes and protein expression in an animal model. Int. J. Impot. Res., 1999, 11(3), 123-132.
24. Cellek, S.; Rodrigo, J.; Lobos, E.; Fernandez, P.; Serrano, J.; Moncada, S. Selective nitrergic neurodegeneration in diabetes mellitus - a nitric oxide-dependent phenomenon. Br. J. Pharmacol., 1999, 128(8), 1804-1812.
25. Zucchi, A.; Arienti, G.; Mearini, L.; Costantini, E.; Bini, V.; Porena, M.; Palmerini, C.A. Recovery of sexual function after nervesparing radical retropubic prostatectomy: is cavernous nitric oxide level a prognostic index? Int. J. Impot. Res., 2006, 18(2), 198-200.
26. Burnett, A.L. Neuroprotection and nerve grafts in the treatment of neurogenic erectile dysfunction J. Urol., 2003, 170(2pt2), S31-S34.
27. Burnett, A.L. Novel nitric oxide signalling mechanisms regulate the erectile response. Int. J. Impot. Res., 2004, 16(Suppl 1), S15-S19.
28. Akingba, A.G.; Burnett, A.L. Endothelial nitric oxide synthase protein expression, localization, and activity in the penis of the alloxan- induced diabetic rat. Mol. Urol., 2001, 5(4),189-197.
29. Carrier, S.; Zvara, P.; Nunes, L.; Kour, N.W.; Rehman J.; Lue, T.F. Regeneration of nitric oxide synthase-containing nerves after cavernous nerve neuorotomy in the rat. J. Urol., 1995, 153(5), 1722-1727.
30. Lin, C.S.; Lue, T.F. Growth factor therapy and neuronal nitric oxide synthase. Int. J. Impot. Res., 2004, 16(Suppl 1), S38-S39.
31. Champion, H.C.; Bivalacqua, T.J.; Hyman, A.L.; Ignarro, L.J.; Hellstrom, W.J.; Kadowitz, P.J. Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat. Proc. Natl. Acad. Sci. USA, 1999, 96 (20), 11648-1152.
32. Magee, T.R.; Ferrini, M.; Garban, H.J.; Vernet, D.; Mitani, K.; Rajfer, J.; Gonzalez-Cadavid, N.F. Gene therapy of erectile dysfunction in the rat with penile neuronal nitric oxide synthase. Biol. Reprod., 2002, 67(3), 1033-1041.
33. Bivalacqua, T.J.; Deng, W.; Champion, H.C.; Hellstrom, W.J.; Kadowitz, P.J. Gene therapy techniques for the delivery of endothelial nitric oxide synthase to the corpora cavernosa for erectile dysfunction. Methods Mol. Biol., 2004, 279, 173-185.
34. Bivalacqua, T.J.; Strong, T.D. The use of gene transfer technology to study the pathophysiology of erectile dysfunction. J. Sex. Med., 2008, 5(2), 268-275.
35. Tran, C.T.; Leiper, J.M.; Vallance, P. The DDAH/ADMA/NOS pathway. Atheroscler. Suppl., 2003, 4(4), 33-40.
36. Lin, K.Y.; Ito, A.; Asagami, T.; Tsuo, P.S.; Adimoolam, S.; Kimoto, M.; Tsuji, H.; Cooke, J.P. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydralase. Circulation, 2002, 106(8), 987-992.
37. Park, K.; Lee, D.G.; Kim, S.W.; Paick, J.S. Dimethylarginine dimethylaminohydrolase in rat penile tissue: reduced enzyme activity is responsible for erectile dysfunction in a rat model of atherosclerosis. Int. J. Impot. Res., 2009, 21(4), 228-234.
38. Mirone, V.; Sorrentino, R.; di Villa Bianca, R.; d'E Imbimbo, C.; Palmieri, A.; Fusco, F.; Tajana, G.; Cirino, G. A standardized procedure for using human corpus cavernosum strips to evaluate drug activity. J. Pharmacol. Toxicol. Methods, 2000, 44(3), 477-482.
39. Wein, A.J.; Van Arsdalen, K.N. Drug-induced male sexual dysfunction. Urol. Clin. North Am., 1988, 15(1), 22-31.
40. Becker, A.J.; Uckert, S.; Stief, C.G.; Truss, M.; Hartmann, U.; Jonas, U. Systemic and cavernosal plasma levels of endothelin (1- 21) during different penile conditions in healthy males and patients with erectile dysfunction. World J. Urol., 2001, 19 (5), 371-376.
41. Lau, D.H.W.; Thompson, C.S.; Bellringer, J.F.; Thomas, P.J.; Mumtaz, F.H.; Morgan, R.J.; Mikhailidis, D.P. Doxazosin and serotonin (5-HT) receptor (1A, 2A, and 4) antagonists inhibit 5-HTmediated human cavernosal contraction. J. Androl., 2006, 27(5), 679-685.